THIRD DEVELOPMENT AGREEMENT AMENDMENT
`
`This Third Amendment is entered into as of 17 April 2013 by and between Novartis Pharma
`AO, with its
`35, CH 4056 Basel, Switzerland
`f
`'
`'
`.
`"Novartis' and
`with its principal offices located at
`and amends the terms of the
`27 January 2009, as amended as
`Development Agreement between Novartis and
`of 22 July 2011 and 19 March 2012 (the "Development Agreement") which terms are hereby
`deemed amended for the purposes hereof and otherwise ratified.
`
`(Page remainder left blank intentionally.)
`
`-1-
`
`Iii
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(US)00006173
`
`Novartis Exhibit 2156.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2156.002
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2156.002
`Regeneron v. Novartis, IPR2021-00816
`
`
Still Working On It
This document is taking longer than usual to download. This can
happen if we need to contact the court directly to obtain the
document and their servers are running slowly.
Give it another minute or two to complete, and then try the
refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
One Moment Please
The filing “”
is large (MB) and is being
downloaded.
Please refresh this page in a few minutes to see if the
filing has been downloaded. The filing will also be emailed
to you when the download completes.
Sealed Document
We are unable to display this document, it may be under a court
ordered seal.
If you have proper credentials to access the file, you may proceed
directly to the court's system using your government issued username
and password.
Access Government Site